5. The Radicality Of Pituitary Adenoma Removal In The Republic Of Kazakhstan
DOI:
https://doi.org/10.35805/BSK2025III005Загрузки
Аннотация
Background. Pituitary adenoma is a common tumor of the chiasmosellar region. By hormonal activity, pituitary adenoma’s are classified as somatotropinomas, non-functioning, prolactinomas, corticotropinomas, and mixed types. Treatment tactics vary by type. Objective: To assess radicality of removal of different pituitary adenoma types in patients operated.
Materials and methods. Retrospective analysis of 929 patients (721 — endoscopic transnasal approach) treated at JSC "National Centre for Neurosurgery" between 2010–2022. Clinical data and magnetic resonance imaging findings were evaluated.
Results. Significant differences in “Extent of Resection” were found among pituitary adenoma types. The highest rate of total resection occurred in mixed tumors compared to prolactinomas (76.5% vs 50%). Subtotal removal was seen in 23.5% of mixed tumors, none had partial resection. Prolactinomas showed total removal in 50%, subtotal in 41.9%, partial in 8.1%. Conservative resection of prolactinomas is linked to their high sensitivity to medical therapy, enabling full recovery with dopamine agonists postoperatively. More radical removal of mixed pituitary adenoma’s is justified by their aggressive behavior and relative drug resistance.
Conclusion. Extent of resection correlates with pituitary adenoma type. Lower radicality in prolactinomas reflects their benign course and responsiveness to drugs, whereas mixed pituitary adenoma’s require aggressive surgery due to severe hormonal disturbances. Greater radicality should be pursued when possible while preserving quality of life. The transnasal endoscopic approach remains the safest and most effective surgical method for pituitary adenoma’s in Kazakhstan, as confirmed by high total resection rates and low postoperative complications.
Ключевые слова
pituitary adenoma, transnasal, endoscopic surgery, Kazakhstan, neurosurgery
Библиографические ссылки
- Daly AF, Beckers A. The Epidemiology of Pituitary Adenomas. Endocrinol Metab Clin North Am. Sep 2020;49(3):347-355. doi:10.1016/j.ecl.2020.04.002
- Araujo-Castro M, Berrocal VR, Pascual-Corrales E. Pituitary tumors: epidemiology and clinical presentation spectrum. Hormones (Athens). Jun 2020;19(2):145-155. doi:10.1007/s42000-019-00168-8
- Tritos NA, Miller KK. Diagnosis and Management of Pituitary Adenomas: A Review. JAMA. Apr 25 2023;329(16):1386-1398. doi:10.1001/jama.2023.5444
- Chin SO. Epidemiology of Functioning Pituitary Adenomas. Endocrinol Metab (Seoul). Jun 2020;35(2):237-242. doi:10.3803/EnM.2020.35.2.237
- Pekic S, Stojanovic M, Popovic V. Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal? Endocr Oncol. Jan 2022;2(1):R1-R13. doi:10.1530/EO-21-0033
- Taghvaei M, Sadrehosseini SM, Ardakani JB, Nakhjavani M, Zeinalizadeh M. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients. World Neurosurg. Sep 2018;117:e259-e268. doi:10.1016/j.wneu.2018.06.009
- Kreutzer E, Short JL, Nicolazzo JA. Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells. Pharm Res. Jul 2024;41(7):1427-1441. doi:10.1007/s11095-024-03731-0
- Riley G, Scheyer N, Klein M, et al. Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complications. Front Endocrinol (Lausanne). 2023;14:1327404. doi:10.3389/fendo.2023.1327404
- Gurses ME, Gokalp E, Gecici NN, et al. The learning curve and outcomes of 1038 endoscopic endonasal transsphenoidal pituitary tumor surgeries - A single surgical team experience. Surg Neurol Int. 2024;15:407. doi:10.25259/SNI_750_2024
- Tao C, Cheng G, Chen Y, Gu P, Hu W. Early outcomes of endoscopic endonasal approach pituitary adenomas resection with minimal nasal injury. Medicine (Baltimore). Nov 19 2021;100(46):e27843. doi:10.1097/MD.0000000000027843
- Shen A, Min Y, Zhou D, et al. Adaptive evaluation of gross total resection rates for endoscopic endonasal approach based on preoperative MRI morphological features of pituitary adenomas. Front Oncol. 2024;14:1481899. doi:10.3389/fonc.2024.1481899
- Godil SS, Tosi U, Gerges M, et al. Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy. J Neurosurg. May 1 2022;136(5):1347-1355. doi:10.3171/2021.5.JNS202011
- Zhang G, Wang P, Wang J, et al. Endoscopic endonasal surgery for non-invasive pituitary neuroendocrinology tumors with incomplete pseudocapsule. Front Neurol. 2023;14:1109388. doi:10.3389/fneur.2023.1109388
- Yagnik KJ, Erickson D, Bancos I, et al. Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis. Pituitary. Dec 2021;24(6):978-988. doi:10.1007/s11102-021-01188-7